VT with Pulse in the Setting of Hypercalcemia

Why Hypercalcemia Causes VT

Calcium plays a central role in cardiac myocyte action potential phase 2 (the plateau phase). Excess extracellular calcium shortens the plateau and action potential duration, which is why the classic ECG finding is a shortened QT interval. In severe hypercalcemia (>14 mg/dL), the membrane becomes increasingly unstable and can generate malignant ventricular arrhythmias. Other ECG findings in hypercalcemia include:

Short QT (most recognized sign, though not always reliable)
ST segment elevation (can mimic STEMI - an important pitfall)
U waves despite normokalemia
Osborn waves despite normothermia
Bradydysrhythmias (most common cardiac finding overall)
Sinus arrest, high-degree AV block
Atrial fibrillation, and at the extreme end - ventricular tachycardia and ventricular fibrillation

ECG from a patient with multiple myeloma and Ca²⁺ of 14.2 mg/dL showing short QT (arrow):

Fig. 114.6 - Rosen's Emergency Medicine

Step 1: Assess Hemodynamic Stability

VT with a pulse must first be classified by hemodynamic status, because this drives everything:

Status	Definition	Immediate Action
Unstable	Hypotension, altered consciousness, chest pain, pulmonary edema	Immediate synchronized cardioversion
Stable	Adequate BP, alert, tolerating the rhythm	Pharmacologic cardioversion first

Step 2: Treat the Underlying Cause - Hypercalcemia

This is the cornerstone. Antiarrhythmics alone will not provide durable termination if the metabolic trigger persists. Treat aggressively and simultaneously:

Aggressive IV Saline (First and Most Important)

Normal saline "wide open" until BP and perfusion normalize
Then 200-300 mL/hr adjusted to patient's renal and cardiac function
Target urine output: ~2 L/day
Saline works by inhibiting proximal tubular reabsorption of calcium

Loop Diuretics

Not routine - furosemide is no longer recommended as standard treatment
Reserve only for volume overload prevention once the patient is volume-replete
Giving furosemide to a volume-depleted patient worsens hypercalcemia

Bisphosphonates (for severe/malignancy-related cases)

Zoledronic acid is the bisphosphonate of choice
Used when Ca²⁺ >15 mg/dL with rapid CNS, cardiac, GI, or renal deterioration
Infusion over 15 minutes; sustained calcium-lowering effect
Mechanism: inhibits osteoclast function and survival

Denosumab

Option for hypercalcemia of malignancy refractory to bisphosphonates

Calcitonin, Glucocorticoids, Mithramycin

Additional osteoclast-inhibiting agents; consult with oncology/endocrinology

Hemodialysis

For life-threatening hypercalcemic arrhythmias or heart block when other measures fail
This is the definitive intervention for refractory cases with cardiac compromise

Treat Electrolyte Co-Disturbances

Monitor potassium closely during saline diuresis - hypokalemia can compound arrhythmia risk
Check and correct magnesium

Step 3: Antiarrhythmic Management of the VT Itself

If Unstable (any sign of hemodynamic compromise):

Immediate synchronized cardioversion (25-50 J for monomorphic VT, higher energy if ineffective)
Airway management and sedation if clinical status allows

If Stable:

Pharmacologic cardioversion is first-line. Per Tintinalli's:

Procainamide - Superior to amiodarone or lidocaine for converting stable VT. Disadvantage: slow infusion required to avoid hypotension
Amiodarone - Commonly used for stable VT; especially for slower, hemodynamically stable VT
Lidocaine - Alternative agent; also consider for post-ROSC maintenance if used for pulseless VT
Magnesium - If hypomagnesemia, polymorphic VT, or QT prolongation is a concern

If the patient deteriorates during pharmacologic treatment, escalate immediately to synchronized cardioversion.

Important Caveats Specific to Hypercalcemia-Induced VT:

Avoid calcium channel blockers (verapamil, diltiazem) - these are not indicated and calcium is already elevated
Avoid agents that prolong QT - though hypercalcemia shortens QT, concomitant electrolyte disturbances (hypokalemia, hypomagnesemia) may coexist
Hemodialysis should be considered early if the VT is refractory and hypercalcemia is severe
Cardiology consult for stable VT refractory to standard pharmacologic therapy - unusual forms may require electrophysiologic evaluation

Disposition

Patients with arrhythmias from hypercalcemia require admission to a monitored ICU-level setting. Involve hematology/oncology and palliative care early if the underlying cause is malignancy.

Summary Algorithm

VT with Pulse + Hypercalcemia
         |
    Hemodynamically stable?
    /                    \
  YES                    NO
   |                      |
Pharmacologic Rx      Immediate Synchronized
(Procainamide 1st,    Cardioversion
 Amiodarone, Lido)
   |
SIMULTANEOUS:
- IV NS wide open → 200-300 mL/hr
- Monitor K+, Mg²⁺
- Bisphosphonate if Ca²⁺ >15 mg/dL
- Hemodialysis if life-threatening/refractory
- Treat underlying cause

Sources: Rosen's Emergency Medicine (9780323757898), Tintinalli's Emergency Medicine (9781260019933), Goldman-Cecil Medicine (9780323930345), Sabiston Textbook of Surgery (9780443124341)

This is a shared conversation. Sign in to Orris to start your own chat.